Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from JD Health International, Inc. ( (HK:6618) ) is now available.
JD Health International Inc. has announced a board meeting scheduled for August 14, 2025, to approve and publish its unaudited interim results for the first half of 2025. The meeting will also consider the recommendation for an interim dividend. The company will host a conference call on the same day to discuss these results, indicating a proactive approach in engaging with stakeholders and maintaining transparency in its financial operations.
The most recent analyst rating on (HK:6618) stock is a Buy with a HK$31.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International Inc. is a company incorporated in the Cayman Islands and operates in the healthcare industry. It focuses on providing health-related services and products, with a market presence in Hong Kong and Mainland China.
Average Trading Volume: 9,515,403
Technical Sentiment Signal: Hold
Current Market Cap: HK$159.8B
Learn more about 6618 stock on TipRanks’ Stock Analysis page.